Stockscreener 앱 받기
10.75
2.48%
0.26
시장 영업 전:
10.80
0.05
+0.47%
전일 마감가:
$10.49
열려 있는:
$10.45
하루 거래량:
17.84M
Relative Volume:
1.87
시가총액:
$12.53B
수익:
$14.33B
순이익/손실:
$-3.79B
주가수익비율:
-3.3912
EPS:
-3.17
순현금흐름:
$1.84B
1주 성능:
+4.67%
1개월 성능:
+5.50%
6개월 성능:
+25.15%
1년 성능:
-7.41%
1일 변동 폭
$10.41
$10.81
1주일 범위
$10.24
$10.81
52주 변동 폭
$6.85
$13.55
비아트리스 Stock (VTRS) Company Profile
명칭
Viatris Inc
전화
(724) 514-1465
주소
1000 MYLAN BOULEVARD, CANONSBURG
VTRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.75 | 12.11B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
120.49 | 55.16B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.59 | 42.84B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.31 | 41.50B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.60 | 23.47B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.45 | 18.83B | 3.08B | 1.24B | 1.07B | 25.61 |
비아트리스 Stock (VTRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-06-06 | 개시 | Goldman | Neutral |
| 2024-07-19 | 재개 | Jefferies | Buy |
| 2023-10-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2023-04-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-02-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-10 | 업그레이드 | UBS | Sell → Neutral |
| 2022-11-08 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2022-06-14 | 개시 | UBS | Sell |
| 2022-05-10 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 개시 | Citigroup | Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 개시 | Argus | Hold |
| 2020-12-14 | 개시 | Bernstein | Mkt Perform |
모두보기
비아트리스 주식(VTRS)의 최신 뉴스
Can Viatris Inc. stock continue upward trendTrade Entry Report & Free Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
Why Viatris Inc. stock could be next big winnerEarnings Beat & Free Daily Entry Point Trade Alerts - fcp.pa.gov.br
Will Viatris Inc. stock go up soon2025 Market Overview & Community Consensus Stock Picks - newser.com
What makes Viatris Inc. (VIA) stock appealing to growth investorsBear Alert & Low Risk Investment Opportunities - fcp.pa.gov.br
Viatris (VTRS) Is Up 5.1% After Announcing AI-Driven Phage Therapy Partnership With Locus Biosciences Has The Bull Case Changed? - simplywall.st
Viatris Q3 Earnings Preview: Eyes on debt, pipeline amid stock slump - MSN
Countdown to Viatris (VTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
United States Hypopituitarism Treatment Market 2025: Industry - openPR.com
Is now a turning point for Viatris Inc.Analyst Downgrade & Consistent Return Strategy Ideas - newser.com
What does recent volatility data suggest for Viatris Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
What dividend safety score for Viatris Inc. stockMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsWeekly Investment Recap & Step-by-Step Swing Trade Plans - newser.com
Is Viatris Inc. stock recession proofRisk Management & Advanced Technical Signal Analysis - newser.com
Will Viatris Inc. stock benefit from upcoming earnings reportsJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Viatris Inc. stock outlook for YEARJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Viatris declares quarterly dividend of $0.12 per share By Investing.com - Investing.com Nigeria
Can volume confirm reversal in Viatris Inc.July 2025 Patterns & Risk Controlled Stock Pick Alerts - newser.com
What is the fair value estimate for Viatris Inc. (VIA) stock in 2025Trade Signal Summary & Daily Oversold Stock Bounce Ideas - newser.com
What’s the recovery path for long term holders of Viatris Inc.2025 Market Overview & Trade Opportunity Analysis - newser.com
Viatris (VTRS) Q3 Earnings Report Preview: What To Look For - Barchart.com
Will Viatris Inc. stock reach Wall Street targetsMarket Activity Recap & Verified Entry Point Signals - newser.com
Will Viatris Inc. stock return to pre crisis levelsQuarterly Profit Report & Stepwise Entry/Exit Trade Alerts - newser.com
Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections - Eyes On Eyecare
Policy Engagement to Break Down Barriers to Access and Build Resilient Health Systems at Viatris - ACCESS Newswire
Viatris Inc. Declares Quarterly Dividend, Payable on December 15, 2025 - MarketScreener
Viatris declares quarterly dividend of $0.12 per share - Investing.com
Viatris Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Is it time to cut losses on Viatris Inc.Trade Signal Summary & Low Risk Entry Point Guides - newser.com
Viatris Announces Quarterly Dividend - PR Newswire
Is Viatris Inc. (VIA) stock overpriced at current multiples2025 Price Momentum & Smart Money Movement Tracker - newser.com
Is Viatris Inc. stock a good choice for value investorsMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Will Viatris Inc. stock recover faster than peersAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Viatris to Report Q3 Earnings: Is a Beat in the Cards for the Stock? - Zacks Investment Research
3 Stocks Under $50 We’re Skeptical Of - The Globe and Mail
Should you wait for a breakout in Viatris Inc.Trade Volume Report & High Return Stock Watch Alerts - newser.com
비아트리스 (VTRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
7.37%
자본화:
|
볼륨(24시간):